A ProPublica story says the U.S. Food and Drug Administration found evidence that a Houston-based laboratory called Cetero, which conducted research for drug companies worldwide, tampered with records and manipulated data.
The story says the violations were found to be so pervasive and “egregious” that the FDA concluded studies conducted there between April, 2005, and August, 2009, might be useless. Yet the agency pulled none of the drugs approved as ...
continue reading...
Many medical professionals are concerned about this week’s decision by the federal appeals court making it legal for pharmaceutical company representatives to market drugs for “off label” uses.
